Candesartan 8mg (Candesartan Cilexetil)

Adult dose

Essential hypertension in adults: An initial and maintenance dose of 8 to 16 mg of Candesartan Cilexetil is recommended, administered orally once daily. If blood pressure is not sufficiently controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased up to a maximum of 32 mg once daily. Heart failure in adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled every 2 weeks or more, depending on patient's tolerance.

Child dose

The safety and efficacy for adolescents and children under the age of 18 have not been established.

This medication can cause serious damage to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Individuals with allergies to this medication or any of its components, pregnant women or those who may become pregnant, breastfeeding women, those with severe liver disease or cholestasis, and individuals with certain hereditary diseases should not use this medication. Elderly patients, those with elevated potassium levels, patients with liver diseases, those with heart valve abnormalities, and patients with poor kidney function should use this medication cautiously and require regular monitoring. During the use of this medication, symptoms such as dizziness, back pain, and respiratory infections may occur, and serious side effects may rarely occur, so patients should consult a healthcare professional immediately if any unusual symptoms occur. In heart failure patients, side effects such as hypotension, hyperkalemia, and worsening kidney function may occur, necessitating regular blood tests and monitoring of condition. When taken in combination with other antihypertensive medications, the blood pressure lowering effect may be amplified, so caution is required upon concomitant use. When used alongside potassium-sparing diuretics or potassium supplements, dangerously elevated blood potassium levels may occur, so caution is needed. This medication can be taken regardless of meals and generally has minimal drug interactions, but caution is required when used alongside certain medications. This medication should not be administered to pregnant or breastfeeding women, and if there are plans to become pregnant or if already pregnant, it is imperative to inform the healthcare provider. The safety and effectiveness for children and adolescents under 18 years of age have not been established, and it is recommended not to use it in this population. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may present, and in such cases, immediate medical attention should be sought. This medication should be stored out of reach of children and should not be transferred to other containers for safety. Dizziness or drowsiness may occur when driving or operating machinery, so caution is necessary.

Serious side effects

Hives, severe swelling (angioedema), difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, exfoliation of the skin, painful mucous membranes in the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances,

Mild side effects

Dizziness, back pain, respiratory infections (upper respiratory infections, pharyngitis, rhinitis), fatigue, peripheral edema, chest pain, headache, bronchitis, cough, sinusitis, nausea, abdominal pain, diarrhea, vomiting, joint pain, proteinuria, weakness, fever, paresthesia, dyspepsia, gastroenteritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, depression, drowsiness, rash, increased sweating, hematuria,

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. Additionally, it is advisable to keep the medication at room temperature between 1 to 30 degrees Celsius, rather than in excessively hot or cold places.

Appearance

Pale pink, round tablet with a biconvex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle, 30 tablets (10 tablets/PTP*3, for export)